All
Sorting through immunomodulatory psoriasis agents
May 1st 2002Norman Levine, M.D., professor and chief of dermatology, University of Arizona, and Gerald G. Krueger, M.D., professor of dermatology, Cumming Presidential Endowed Chair, University of Utah, discuss immunomodulatory agents in the treatment of psoriasis.
Greater UVA protection equates to improved immune protection
May 1st 2002New Orleans - The level of UVA protection afforded by a broad-spectrum sunscreen determines its ability to protect against UV-induced immune suppression, according to a study presented by Dominique Moyal, Ph.D., at the annual meeting of the American Academy of Dermatology.
One percent PTZ shampoo increases hair density
May 1st 2002New Orleans - Regular use of a commercially available antidandruff shampoo containing 1 percent pyrithione zinc (PTZ) does not adversely affect hair loss in men with androgenetic alopecia and may in fact slow its progression or result in improvement, according to the results of a prospective, randomized, controlled investigation.
Intralesional plus steroid offers eyebrow regrowth
May 1st 2002New Orleans - Combined intralesional and topical corticosteroid treatment can be effective for reversing eyebrow hair loss in patients with alopecia totalis and alopecia universalis, Jordana S. Gilman, M.D., reported at the annual meeting of the American Academy of Dermatology.
Ambulatory phlebectomy easily handled
April 1st 2002New Orleans - Ambulatory phlebectomy is a safe and effective outpatient procedure for treating varicose and reticular veins that offers a host of advantages compared with alternative techniques, Mitchel P. Goldman, M.D., said at the annual meeting of the American Academy of Dermatology.
The right stuff: a primer in closing of wounds
April 1st 2002New Orleans - Suture materials and needle choices for clinicians can seem to be limitless, according to Margaret Terhune, M.D. Dr. Terhune presented a thorough review of the materials and methods surgeons can select for wound closure here at the annual meeting of the American Academy of Dermatology.
Lesion size, location dictate decision on pediatric surgery
April 1st 2002New Orleans - Timing is key for a successful outcome when performing dermatologic surgery in pediatric patients, and lesion size and location are the two most important variables factoring into the equation, Annette M. Wagner, M.D., said at the annual meeting of the American Academy of Dermatology.
Systemic CD often an elusive diagnosis
April 1st 2002New Orleans - Systemic contact dermatitis may present with a variety of eczematous and noneczematous cutaneous reaction patterns and may be an overlooked diagnosis unless clinicians maintain an index of suspicion that systemic exposure to a contact allergen is driving the skin eruption, Donald V. Belsito, M.D., said at the annual meeting of the American Academy of Dermatology.
Skin manifestations signal hepatitis C virus infection
April 1st 2002New Orleans - Dermatologists need to be aware that hepatitis C virus (HCV) infection may present with cutaneous manifestations because early diagnosis and treatment are critical for reducing morbidity and mortality from progression of the underlying infectious disease, Julia R. Nunley, M.D., said at the annual meeting of the American Academy of Dermatology.
MF remains diagnosis, treatment challenge
April 1st 2002New Orleans - Even with fairly recent advances in the testing and treatment of mycosis fungoides, difficulties still remain with the diagnosis of the rare, slowly progressing cutaneous lymphoma, David P. Fivenson, M.D., said at the annual meeting of the American Academy of Dermatology.
Multiple strategies improve patient comfort during 5-ALA PDT
April 1st 2002New Orleans - Simple measures can help alleviate any burning and stinging experienced by patients undergoing 5-ALA photodynamic therapy for treatment of actinic keratoses, Joseph Fowler, Jr., M.D., said at the annual meeting of the American Academy of Dermatology.
BCC risk in rhinophyma patients should be taken into account
April 1st 2002New Orleans - Rhinophyma resection needs to be performed in a way that allows for postoperative histopathologic study, according to Luis A. Lopardo, MD, speaking here at the 60th annual meeting of the American Academy of Dermatology.
Infliximab finds utility in management of pyoderma gangrenosum
April 1st 2002New Orleans - The experiences of an expanding series of patients indicate infliximab (Remicade) is a valuable therapy for the management of pyoderma gangrenosum (PG), Marketa Limova, M.D., said at the annual meeting of the American Academy of Dermatology.
Lengthy remission rates uphold alefacept quality of life benefits
April 1st 2002Maui, Hawaii - Alefacept (Amevive) for treating patients with chronic plaque psoriasis provides clinical benefits that may be long-term and are associated with significant improvement in quality of life, Mark Lebwohl, M.D., said at the 26th annual Hawaii Dermatology Seminar.